OpenURL Connection Search

Select item for more details and to access through your institution.

Point mutants of EHEC intimin that diminish Tir recognition and actin pedestal formation highlight a putative Tir binding pocket.
Published in:
Molecular Microbiology, 2002, v. 45, n. 6, p. 1557, doi. 10.1046/j.1365-2958.2002.03137.x
By:
- Liu, Hui;
- Radhakrishnan, Padhma;
- Magoun, Loranne;
- Prabu, Moses;
- Campellone, Kenneth G.;
- Savage, Pamela;
- He, Feng;
- Schiffer, Celia A.;
- Leong, John M.
Publication type:
Article
EXTH-42. CANSCRIPT MAY PREDICT A SUBSET OF GLIOBLASTOMAS THAT RESPOND TO SP1 BLOCKERS.
Published in:
Neuro-Oncology, 2018, v. 20, p. vi94, doi. 10.1093/neuonc/noy148.390
By:
- Ray, Amitava;
- Thiyagarajan, Sarvanan;
- Majumdar, Biswanath;
- Radhakrishnan, Padhma;
- Kamath, Ajith;
- Kumar, Dilli;
- Majumdar, Pradip
Publication type:
Article
Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity.
Published in:
Nature Communications, 2015, v. 6, n. 2, p. 6169, doi. 10.1038/ncomms7169
By:
- Majumder, Biswanath;
- Baraneedharan, Ulaganathan;
- Thiyagarajan, Saravanan;
- Radhakrishnan, Padhma;
- Narasimhan, Harikrishna;
- Dhandapani, Muthu;
- Brijwani, Nilesh;
- Pinto, Dency D.;
- Prasath, Arun;
- Shanthappa, Basavaraja U.;
- Thayakumar, Allen;
- Surendran, Rajagopalan;
- Babu, Govind K.;
- Shenoy, Ashok M.;
- Kuriakose, Moni A.;
- Bergthold, Guillaume;
- Horowitz, Peleg;
- Loda, Massimo;
- Beroukhim, Rameen;
- Agarwal, Shivani
Publication type:
Article
Prediction of anticancer drug response in an adjuvant clinical setting for breast cancers by ex vivo live tumor phenotypic assay platform.
Published in:
Journal of Cancer Research & Therapeutics, 2017, v. 13, p. S452
By:
- Nath, Partha;
- Murmu, Nabendu;
- Mitra, Debarpan;
- Oliyarashi, Muthusami;
- Rajappa, Manoj;
- Mehrotra, Debapriya Ghosh;
- Radhakrishnan, Padhma;
- Thiyagarajan, Saravanan;
- Majumder, Biswanath;
- Majhi, Tapas
Publication type:
Article
Phosphoproteomic analysis identifies CLK1 as a novel therapeutic target in gastric cancer.
Published in:
Gastric Cancer, 2020, v. 23, n. 5, p. 796, doi. 10.1007/s10120-020-01062-8
By:
- Babu, Niraj;
- Pinto, Sneha M.;
- Biswas, Manjusha;
- Subbannayya, Tejaswini;
- Rajappa, Manoj;
- Mohan, Sonali V.;
- Advani, Jayshree;
- Rajagopalan, Pavithra;
- Sathe, Gajanan;
- Syed, Nazia;
- Radhakrishna, Vinod D.;
- Muthusamy, Oliyarasi;
- Navani, Sanjay;
- Kumar, Rekha V.;
- Gopisetty, Gopal;
- Rajkumar, Thangarajan;
- Radhakrishnan, Padhma;
- Thiyagarajan, Saravanan;
- Pandey, Akhilesh;
- Gowda, Harsha
Publication type:
Article

Found: 5

Point mutants of EHEC intimin that diminish Tir recognition and actin pedestal formation highlight a putative Tir binding pocket.

EXTH-42. CANSCRIPT MAY PREDICT A SUBSET OF GLIOBLASTOMAS THAT RESPOND TO SP1 BLOCKERS.

Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity.

Prediction of anticancer drug response in an adjuvant clinical setting for breast cancers by ex vivo live tumor phenotypic assay platform.

Phosphoproteomic analysis identifies CLK1 as a novel therapeutic target in gastric cancer.